Frequency and Severity of Gastrointestinal Adverse Events in Semaglutide Clinical Trials: Key Insights and Findings
Overview of Semaglutide in Clinical Trials Semaglutide, a GLP-1 receptor agonist, plays a significant role in managing type 2 diabetes and obesity. It helps in enhancing glycemic control and promoting weight loss. This section discusses the mechanism of GLP-1 receptor agonists like semaglutide and their impact on blood sugar and body weight. Mechanism of Action […]
